Documentdetail
ID kaart
oai:pubmedcentral.nih.gov:1063...
Onderwerp
ArticleAuteur
Soos, Brandy-Lee Ballinger, Alec Weinstein, Mykayla Foreman, Haley Grampone, Julianna Weafer, Samuel Aylesworth, Connor King, Benjamin L.Langue
enEditor
Cold Spring Harbor Laboratory
Categorie
biorxiv
Jaar
2023
vermelding datum
15-11-2023
Trefwoorden
influenza innate immune zebrafish infection modelBeschrijving
Influenza virus infection can cause severe respiratory disease and is estimated to cause millions of illnesses annually.
Studies of the contribution of the innate immune response to influenza A virus (IAV) to viral pathogenesis may yield new antiviral strategies.
Zebrafish larvae are useful models to study the innate immune response to pathogens, including IAV, in vivo .
Here, we demonstrate how Color-flu, four fluorescent IAV strains originally developed for mice, can be used to study host-virus interactions by simultaneously monitoring virus particles, neutrophils, and macrophages in vivo .
Using this model, we show how the angiotensin-converting enzyme inhibitor, ramipril, and mitophagy inhibitor, MDIVI-1, improved survival, decreased viral burden, and improved the respiratory burst response to IAV infection.
The Color-flu zebrafish model of IAV infection is complementary to other models as it is the only model where interactions between virus particles and host cells in an intact vertebrate can be visualized in vivo .
Soos, Brandy-Lee,Ballinger, Alec,Weinstein, Mykayla,Foreman, Haley,Grampone, Julianna,Weafer, Samuel,Aylesworth, Connor,King, Benjamin L., 2023, Multi-spectral Fluorescent Reporter Influenza A Viruses Allow for in vivo Studies of Innate Immune Function in Zebrafish , Cold Spring Harbor Laboratory
Choice Between Partial Trajectories: Disentangling Goals from Beliefs
agents models aligned based bootstrapped learning reward function model return choice choices partial
Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review
aes medications bta incidence migraine drugs disorders
